The Paris Life Sciences and Technology team advised GFBiochemicals, a leading sustainable chemical company and its founder, Mathieu Flamini, in its €15 million Series A fundraising.
Led by Soﬁnnova Partners, with participation from Sparta Capital, this funding round will accelerate GFBiochemicals’ mission to end chemical pollution.
Founded in 2010, GFBiochemicals provides the companies who make our everyday products with safe, sustainable solvents and ingredients derived from the biobased levulinic molecule. This molecule has been identiﬁed by the U.S. Department of Energy as one of the 12 molecules that can help unlock a “greener” world.
The Goodwin team was led by Benjamin Garçon and included Louis Taslé d’Héliand and Héloïse Bertin on corporate aspects.